Abstract
Introduction: Pneumonia is associated with substantial morbidity and mortality, with disease severity varying considerably among patients. Early identification of severe pneumonia is essential for timely management and appropriate risk stratification. Selected inflammatory biomarkers may provide complementary information regarding disease severity. Objective: To assess the association of selected biomarkers with pneumonia severity and determine their independent association with severe pneumonia. Methods & Materials: This retrospective observational study included 151 patients with pneumonia treated at Uttara Adhunik Medical College Hospital, Dhaka, from January to December 2025. Clinical characteristics and biomarkers (WBC, NLR, CRP, and procalcitonin) were assessed. Pneumonia severity was classified using CURB-65, with scores <3 as non-severe and 3-5 as severe. Biomarkers were compared between groups, and multivariable logistic regression identified independent predictors of severe pneumonia. Results: Among 151 patients, 65.6% had non-severe and 34.4% severe pneumonia. WBC, NLR, CRP, and procalcitonin were significantly higher in severe cases (all p<0.001). Age >65 years, COPD, and SpO₂ <90% were independent predictors of severe pneumonia. Elevated WBC (>15 × 10⁹/L), NLR (>10), CRP (>100 mg/L), and procalcitonin (>0.5 ng/mL) were also independently associated with severe disease. Conclusion: Elevated WBC count, NLR, CRP, and procalcitonin were significantly associated with severe pneumonia and remained independently associated after adjustment for relevant clinical factors. These selected biomarkers may provide useful complementary information for early identification and risk stratification of patients with severe pneumonia.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 The Insight




PDF